RadNet, Inc.
RDNT
Rang in aandelen
#3213
RadNet, Inc. operates as a prominent healthcare services company specializing... RadNet, Inc. operates as a prominent healthcare services company specializing in outpatient diagnostic imaging across the United States. Their comprehensive offerings span a broad spectrum of advanced imaging techniques, including magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, and general diagnostic radiology, along with various specialized procedures. Beyond direct patient services, the company also plays a significant role in developing and marketing specialized computerized systems for the diagnostic imaging sector, such as picture archiving communication systems (PACS) and associated support. Furthermore, RadNet is at the forefront of integrating artificial intelligence (AI) solutions, designing and deploying AI suites to augment radiologist interpretation, particularly in mammography, and extending these AI capabilities to lung and prostate cancer diagnostics. As of December 31, 2021, its operational footprint included ownership and management of 347 centers situated across seven states: Arizona, California, Delaware, Florida, Maryland, New Jersey, and New York. Established in 1981, the company maintains its headquarters in Los Angeles, California.
Aandeelprijs
$70.74
Marktkapitalisatie
$5.57B
Verandering (1 dag)
2.13%
Verandering (1 jaar)
-9.81%
Land
US
Handel RadNet, Inc. (RDNT)
Categorie
Healthcare
Aantal uitstaande aandelen voor RadNet, Inc. (RDNT)
Aantal uitstaande aandelen per June 2026: 77.79M
Volgens de laatste financiële rapporten en de aandelenkoers van RadNet, Inc. bedraagt het huidige aantal uitstaande aandelen 77.79M. Aan het einde van December 2023 had het bedrijf 63.58M uitstaande aandelen. Het aantal uitstaande aandelen wordt meestal beïnvloed door aandelensplitsingen en terugkoop van aandelen.
Geschiedenis van uitstaande aandelen van RadNet, Inc. (RDNT) van 2000 tot 2026
Uitstaande aandelen aan het einde van elk jaar
| Jaar | Uitstaande aandelen | Wijzigen |
|---|---|---|
| 2026 (TTM) | 77.79M | 6.51% |
| 2024 | 73.04M | 14.87% |
| 2023 | 63.58M | 12.94% |
| 2022 | 56.29M | 7.23% |
| 2021 | 52.50M | 3.15% |
| 2020 | 50.89M | 2.45% |
| 2019 | 49.67M | 3.24% |
| 2018 | 48.11M | 2.63% |
| 2017 | 46.88M | 1.38% |
| 2016 | 46.24M | 5.57% |
| 2015 | 43.81M | 6.66% |
| 2014 | 41.07M | 4.93% |
| 2013 | 39.14M | 3.68% |
| 2012 | 37.75M | 1.03% |
| 2011 | 37.37M | 1.40% |
| 2010 | 36.85M | 2.24% |
| 2009 | 36.05M | 0.91% |
| 2008 | 35.72M | 3.26% |
| 2007 | 34.59M | 64.62% |
| 2006 | 21.01M | 1.99% |
| 2005 | 20.60M | 0.70% |
| 2004 | 20.46M | 8.30% |
| 2003 | 18.89M | -7.57% |
| 2002 | 20.44M | 2.29% |
| 2001 | 19.98M | 2.48% |
| 2000 | 19.50M | 0.00% |
Uitstaande aandelen van vergelijkbare bedrijven of concurrenten
| Bedrijf | Uitstaande aandelen | Verschil | Land |
|---|---|---|---|
| 371.00M | 376.93% |
US
|
|
| 705.30M | 806.69% |
US
|
|
| 143.28M | 84.19% |
US
|
|
| - | - |
CN
|
|
| 282.00M | 262.52% |
US
|
